Improving cancer treatment through efficient clinical trials
Official title: Core B: Clinical Trials Core
Funded at University of Michigan at Ann Arbor · NIH-10917038 · Data updated 2026-11-12
This study is working to make it easier and faster to test new cancer treatments at the University of Michigan, so that patients can benefit from the latest discoveries more quickly and effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | August 14, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $235,835 |
| NIH project number | 5P50CA269022-02 |
| Project ID | NIH-10917038 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals diagnosed with locally advanced cancers who are seeking innovative treatment options.
✕Less likely to help
Patients with early-stage cancers or those not eligible for clinical trials may not benefit from this research.
What this research studies
This research focuses on enhancing the process of conducting clinical trials for cancer treatments at the University of Michigan Rogel Cancer Center. It aims to streamline the transition of basic science discoveries into clinical applications, ensuring that new therapies can be tested quickly and effectively. The project will establish a robust infrastructure to support all phases of clinical trials, including participant recruitment, informed consent, and adherence to Good Clinical Practice standards. By coordinating efforts among various departments, the research seeks to improve the overall efficiency and success rates of cancer trials.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective cancer treatments for patients.
How similar studies have gone: Previous research has demonstrated that streamlined clinical trial processes can significantly enhance patient outcomes and treatment efficacy.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Schuetze, Scott Michael — University of Michigan at Ann Arbor
- Study coordinator: Schuetze, Scott Michael
Related research
Other NIH-funded projects on the same topics.
-
Expanding genetic testing for cancer risk in patients and families
This study is working to make it easier for cancer patients in Michigan to get genetic testing for cancer risk by improving how doctors gather family history and assess genetic risks, so that more people can receive the important evaluations they need.
-
HEARTS hypertension and diabetes care in Guatemala
This grant tests how well the HEARTS primary care model works in Guatemala to improve blood pressure and blood sugar control for patients.
-
Why the retina can sometimes heal itself and how we might help it heal
This NIH grant explores how inflammation and neural cells interact in the zebrafish retina to understand retinal neuron death and regeneration, with potential implications for human vision.
-
Integrated Heart Health: A HEARTS-based approach to hypertension and diabetes in Guatemala
A study tests a team-based, stepwise care model to improve blood pressure and blood sugar control for people with both hypertension and diabetes in Guatemala.
-
Understanding how work exposures and genes influence ALS risk
A study is building a long-term group of people at higher risk for ALS to see how their jobs, exposures at work, and genes together affect if and when the disease might develop.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.